Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8794038 | Ophthalmology | 2018 | 9 Pages |
Abstract
These findings do not support the classification of DIF-negative patients, meeting the clinical criteria for ocular MMP, as having a different disease. This category of patients should be accepted as having DIF-negative MMP, for clinical management purposes, with patients having inflamed eyes being treated with systemic immunomodulatory therapy. The frequent finding of asymptomatic ocular, oral, and nasopharyngeal MMP is clinically significant and implies that these sites should be routinely screened in asymptomatic patients.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Hon Shing MBBS, FRCOphth, Jane F. MD, FRCP, Darwin C. MSc(Epidem), FRCOphth, John K. DM, FRCOphth,